Journal of Pediatric Health Care
Volume 23, Issue 3 , Pages 158-164 , May 2009

Brief Report: Language Ability and School Functioning of Youth Perinatally Infected With HIV

References 

  1. Belman AL, Muenz LR, Marcus JC, Goedert JJ, Landesman S, Rubenstein A, et al. Neurologic status of human immunodeficiency virus 1-infected infants and their controls: A prospective study from birth to 2 years. Pediatrics. 1996;98(6 Pt 1):1109–1118
  2. Brouwers P, Belman AL, Epstein LG. Central nervous system involvement: Manifestations and evaluation. In:  Pizzo P,  Wilfert C editor. Pediatric AIDS: The challenge of HIV infection in infants, children and adolescents. Baltimore: Williams & Wilkins; 1991;p. 318–335
  3. Chiriboga CA, Fleishman S, Champoin S, Gaye-Robinson L, Abrams EJ. Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART). Journal of Pediatrics. 2005;146:402–407
  4. Cooper ER, Hanson C, Diaz C, Mendez H, Abboud R, Nugent R, et al. Encephalopathy and progression for human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection (Women and Infants Transmission Study Group). Journal of Pediatrics. 1998;132:808–812
  5. Coplan J, Contello KA, Cunningham CK, Weiner LB, Dye TD, Roberge L, et al. Early language development in children exposed to or infected with human immunodeficiency virus. Pediatrics. 1998;102:8
  6. Coscia JM, Christensen BK, Henry RR, Wallston K, Radcliffe J, Rutstein R. Effects of home environment, socioeconomic status, and health status on cognitive functioning in children with HIV-1 infection. Journal of Pediatric Psychology. 2001;26:321–329
  7. Dunn L, Dunn L. Peabody picture vocabulary test: Examiner's manual. (3rd ed.). Circle Pines, MN: American Guidance Service; 1997;
  8. Epstein LG, Sharer LR, oudsmit J. Neurological and neuropathological features of human immunodeficiency virus infection in children. Annals of Neurology. 1988;23:S19–S23
  9. Goldschmidt L, Richardson GA, Corneliius MD, Day NL. Prenatal marijuana and alcohol exposure and academic achievement at age 10. Neurotoxicology and Teratology. 2004;26:521–532
  10. Gutman M, Sameroff AJ, Eccles JS. The academic achievement of African American students during early adolescence: An examination of multiple risk, promotive, and protective factors. American Journal of Community Psychology. 2002;30:367–399
  11. Halpern CT, Joyner K, Udry R, Suchindran C. Smart teens don't have sex (or kiss much either). Journal of Adolescent Health. 2000;26:213–225
  12. Haubrich RH, Little SJ, Currier JS, Forthal DN, Kemper CA, Beall GN, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic responses. AIDS. 1999;13:1099–1107
  13. Hinkin CH, Castellon SA, Durvasula RS, Hardy DJ, Lam MN, Mason KL, et al. Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59:1944–1950
  14. Jeremy RJ, Kim S, Nozyce M, Nachman S, McIntosh K, Pelton SI, et al. Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children. Pediatrics. 2005;115:380–387
  15. Johnston L, Bachman J, O'Malley P. Monitoring the future: A continuing study of the lifestyle and values of youth. Ann Arbor: University of Michigan; 1993;Institute for Social Research
  16. Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2007). Monitoring the future national survey results on drug use, 1975-2006. Volume I: Secondary school students (NIH publication No. 07-6205). Bethesda, MD: National Institute on Drug Abuse.
  17. Klein K, Forehand R. Family processes as resources for African American children exposed to a constellation of sociodemographic risk factors. Journal of Clinical Child Psychology. 2000;29:53–65
  18. Lobato MN, Caldwell MB, Ng P, Oxtoby MJ. Encephalopathy in children with perinatally acquired human immunodeficiency virus infection. Pediatric Spectrum of Disease Clinical Consortium. Journal of Pediatrics. 1995;126:1–5
  19. Loeber R, Drinkwater M, Yin Y, Anderson SJ, Schmidt LC, Crawford A. Stability of family interaction from ages 6 to 18. Journal of Abnormal Child Psychology. 2000;28:353–369
  20. Loeber R, Stouthamer-Loeber M. Family factors as correlates and predictors of juvenile conduct problems and delinquency. In:  Morris N,  Tonry M editor. Crime and justice. vol. 7:Chicago: University of Chicago Press; 1986;p. 29–149
  21. Loeber R, Stouthamer-Loeber M, Van Kammen W, Farrington DP. Initiation, escalation and desistance in juvenile offenders and their correlates. Journal of Criminal Law & Criminology. 1991;82:36–82
  22. Luster T, McAdoo HP. Factors related to the achievement and adjustment of young African American children. Child Development. 1994;65:1080–1094
  23. Manisha SC, Rutstein RM, Zaoutis T, Zhao H, Chao D, Radcliffe J. Neurocognitive functioning in pediatric human immunodeficiency virus infection: Effects of combined therapy. Archives of Pediatric and Adolescent Medicine. 2005;159:651–656
  24. Martin SC, Wolters P, Toledo-Tamula MA, Zeichner SL, Hazra R, Civitello L. Cognitive functioning in school-aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART). Developmental Neuropsychology. 2006;30:633–657
  25. Mellins CA, Brackis-Cott E, Dolezal C, Abrams E. Psychiatric disorders in perinatally human immunodeficiency virus-infected youth. Pediatric Infectious Disease Journal. 2006;25:432–437
  26. Mellins CA, Levenson RL, Zawadzki R, Kairam R, Weston M. Effects of pediatric HIV-infection and pre-natal drug exposure on mental and psychomotor development. Journal of Pediatric Psychology. 1994;19:617–628
  27. Moos RH, Moos BS. Evaluating correctional and community settings. In:  Moos RH editors. Families. New York: Wiley; 1975;p. 263–286
  28. New York City Department of Health and Mental Hygiene. Pediatric and adolescent HIV/AIDS surveillance update. New York: Author; 2006;
  29. Pulsifer MB, Aylward EH. Human immunodeficiency virus. In:  Yeates KO,  Ris MD,  Taylor HG editor. Pediatric neuropsychology: Research, theory, and practice. New York: Guilford Press; 2000;p. 381–402
  30. Rigardetto R, Vigliano P, Boffi P, Marotta C, Raino E, Arfelli P, et al. Evolution of HIV-1 encephalopathy in children. Panminerva Medica. 1999;41:21–26
  31. Shaw RR. The relationship between pediatric HIV infection, CD4 percentage, HAART, and WISC-III performance. Dissertation Abstracts International Section A: Humanities and Social Sciences. 2007;68(1-A):86
  32. Silver EJ, Bauman LJ, Coupey SM, Doctors SR, Boeck MA. Ego development and chronic illness in adolescents. Journal of Personality and Social Psychology. 1990;59:305–310
  33. Skinner HA, Steinhauer PD, Santa-Barbara J. The family assessment measure. Canadian Journal of Community Mental Health. 1983;2:91–105
  34. Van Dyke RB, Lee S, Johnson GM, Wiznia A, Mohan K, Stanley K, et al. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics. 2002;109:E61
  35. Wagner GJ. Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries. AIDS Patient Care and STDs. 2002;16:599–608
  36. Wilkinson GS. Wide range achievement test. (3rd ed.). Lutz, FL: PAR/Psychological Assessment Resources, Inc; 1993;

 This research was supported by a supplemental research grant from the Office of AIDS Research to National Institute of Mental Health (R01-MH6 3636-01; principal investigator: Claude Ann Mellins, PhD), and a center grant from the National Institute of Mental Health to the HIV Center for Clinical and Behavioral Studies at New York State Psychiatric Institute and Columbia University (P50-MH43520; Center principal investigator: Anke A. Ehrhardt, PhD).

PII: S0891-5245(08)00053-9

doi: 10.1016/j.pedhc.2008.02.005

Journal of Pediatric Health Care
Volume 23, Issue 3 , Pages 158-164 , May 2009

Article Tools